Hello, Fool! | Login | Signup | My Fool
Aug 21, 2008 10:36 PM ET | Site Changes | Help
A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.
View Ticker Page (MRK)
Results 41 - 50 of 310 : 12345Next »
Recs
toddschenk (28.51) Submitted: 2/07/07 5:11 PM : Start Price: $41.93 MRK Score: -5.23
Was hurt by Vioxx conection with heart attacks, but most doctors still think this is a good drug. Latest drug GARDASIL was recently approved by FDA is a vaccine for woman against cervical cancer. Many states have already started considering legisla...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Bigbruizer (88.35) Submitted: 9/19/06 5:20 AM : Start Price: $39.09 MRK Score: -7.66
Undervalued still even after rising over 40. Pays a good dividend and has good pipeline. Concern over law suits is over done
Paganpink (< 20) Submitted: 2/02/07 4:35 PM : Start Price: $42.49 MRK Score: -6.37
In spite of their many products whose patents expire over the next year they have a number of highly exciting new treatments in the pipeline, several of which could be blockbusters. That is coupled with one of the best trained and most competent sal...
jay4290210 (< 20) Submitted: 9/19/06 8:52 PM : Start Price: $39.25 MRK Score: -8.27
that cancer vaccine is way underrated!
HGBG (< 20) Submitted: 6/28/06 7:58 PM : Start Price: $33.55 MRK Score: 0.92
Merck is an excellent, long term investment. It's share price is currently low because of the impact from legal suits.Merck's management team will eventually recover from the Vioxx legal suits. Once this happens, we're looking at a business whic...
jeffini (72.02) Submitted: 8/24/06 9:32 PM : Start Price: $37.91 MRK Score: -6.78
Their business continues to be strong, their income is superior, they have lots of new drugs coming down the pike. They will overcome the liability challenges... heck they've gone up over 30% in the past 9 months. why not back to $90 per share with...
Aiden1976 (78.91) Submitted: 3/31/08 12:14 PM : Start Price: $37.34 MRK Score: -3.53
The unstable drop on the day when the day of Vytorin study shown on press. But it will come back up because this company still have very good drugs other than Vytorin. and well manage company
farmerscotty (< 20) Submitted: 4/11/08 9:39 AM : Start Price: $41.32 MRK Score: -10.77
it is poised to make some good gains things are in place for good things to happen here
ccbiker (< 20) Submitted: 3/27/08 2:21 PM : Start Price: $44.10 MRK Score: 16.94
a good company with a great leader. Lots of insider sales in the last 9 months
GCrackers101 (77.66) Submitted: 3/26/08 1:09 AM : Start Price: $44.09 MRK Score: -16.07
Oversold, big turnaround no matter who is in the White House.......one of the few that seems to value ethics.
Terms & Conditions
RSS Headlines
Fool UK